Emergency use of sugammadex after failure of standard reversal drugs
- PMID: 17312213
- DOI: 10.1213/01.ane.0000253231.76654.45
Emergency use of sugammadex after failure of standard reversal drugs
Abstract
Administration of sugammadex, 350 mg IV (4 mg/kg), in the postanesthesia care unit immediately (<60 s) relieved acute respiratory distress due to residual neuromuscular blockade in a 42-yr-old patient with chronic renal failure who had received vecuronium, 10 mg IV, for tracheal intubation, after inadequate reversal of neuromuscular blockade in the operating room with neostigmine, 5 mg IV, and glycopyrrolate, 1 mg IV.
Comment in
-
Was it a true emergency?Anesth Analg. 2007 Sep;105(3):876-7; author reply 878. doi: 10.1213/01.ane.0000268704.80213.fe. Anesth Analg. 2007. PMID: 17717254 No abstract available.
-
Pseudo-emergent use of an investigational drug.Anesth Analg. 2007 Sep;105(3):876; author reply 876, 878. doi: 10.1213/01.ane.0000268702.75645.c0. Anesth Analg. 2007. PMID: 17717255 No abstract available.
-
Where's the Fire?Anesth Analg. 2007 Sep;105(3):877-8; author reply 878. doi: 10.1213/01.ane.0000268706.67403.61. Anesth Analg. 2007. PMID: 17717256 No abstract available.
-
Urgent usage of sugammadex to treat residual neuromuscular blockade in the PACU.Anesth Analg. 2007 Sep;105(3):877; author reply 878. doi: 10.1213/01.ane.0000268705.04400.10. Anesth Analg. 2007. PMID: 17717257 No abstract available.
Similar articles
-
Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.Anesth Analg. 2007 Mar;104(3):569-74. doi: 10.1213/01.ane.0000248224.42707.48. Anesth Analg. 2007. PMID: 17312210 Clinical Trial.
-
Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.Anesth Analg. 2010 Jan 1;110(1):64-73. doi: 10.1213/ane.0b013e3181ac53c3. Epub 2009 Aug 27. Anesth Analg. 2010. PMID: 19713265 Clinical Trial.
-
Reversal of neuromuscular block with a selective relaxant-binding agent: sugammadex.Am J Ther. 2009 Jul-Aug;16(4):295-9. doi: 10.1097/MJT.0b013e31817fe2d7. Am J Ther. 2009. PMID: 19535969 Review.
-
Neuromuscular transmission: new concepts and agents.J Crit Care. 2009 Mar;24(1):36-42. doi: 10.1016/j.jcrc.2008.08.004. Epub 2009 Jan 17. J Crit Care. 2009. PMID: 19272537 Review.
-
Preclinical pharmacology of sugammadex.J Crit Care. 2009 Mar;24(1):29-35. doi: 10.1016/j.jcrc.2008.10.010. J Crit Care. 2009. PMID: 19272536
Cited by
-
Sugammadex for Reversal of Neuromuscular Blockade in a Patient With Renal Failure.J Pediatr Pharmacol Ther. 2019 May-Jun;24(3):238-241. doi: 10.5863/1551-6776-24.3.238. J Pediatr Pharmacol Ther. 2019. PMID: 31093024 Free PMC article.
-
A miracle that accelerates operating room functionality: sugammadex.Biomed Res Int. 2014;2014:945310. doi: 10.1155/2014/945310. Epub 2014 Aug 14. Biomed Res Int. 2014. PMID: 25202709 Free PMC article.
-
Perioperative Care of Elderly Surgical Outpatients.Drugs Aging. 2017 Sep;34(9):673-689. doi: 10.1007/s40266-017-0485-3. Drugs Aging. 2017. PMID: 28808946 Review.
-
Sugammadex in Emergency Situations.J Pers Med. 2023 Jan 15;13(1):159. doi: 10.3390/jpm13010159. J Pers Med. 2023. PMID: 36675820 Free PMC article.
-
Emergency use of sugammadex after failure of standard reversal drugs and postoperative pulmonary complications: A retrospective cohort study.J Anaesthesiol Clin Pharmacol. 2023 Apr-Jun;39(2):232-238. doi: 10.4103/joacp.joacp_289_21. Epub 2023 Mar 1. J Anaesthesiol Clin Pharmacol. 2023. PMID: 37564851 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources